Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder
17-环丙基甲基-3,14-二羟基-4,5-环氧-6-[(3'-氟-4'-吡啶基)乙酰氨基]吗啡喃 (NFP) 作为双选择性 MOR/KOR 配体的药理学表征及其在治疗阿片类药物使用障碍中的潜在应用
期刊:European Journal of Pharmacology
影响因子:4.2
doi:10.1016/j.ejphar.2019.172812
Yi Zheng, Samuel Obeng, Bethany A Reinecke, Chongguang Chen, Palak S Phansalkar, David M Walentiny, Phillip M Gerk, Lee-Yuan Liu-Chen, Dana E Selley, Patrick M Beardsley, Yan Zhang